Skip to main content
Article
Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma
Surgery Publications and Presentations
  • Melissa M. Murphy, University of Massachusetts Medical School
  • Jessica P. Simons, University of Massachusetts Medical School
  • Sing Chau Ng, University of Massachusetts Medical School
  • Theodore P. McDade, University of Massachusetts Medical School
  • Jillian K. Smith, University of Massachusetts Medical School
  • Shimul A. Shah, University of Massachusetts Medical School
  • Zheng Zhou, University of Massachusetts Medical School
  • Craig C. Earle, Institute for Clinical Evaluative Sciences
  • Jennifer F. Tseng, University of Massachusetts Medical School
UMMS Affiliation
Department of Surgery; Senior Scholars Program
Date
11-1-2009
Document Type
Article
Medical Subject Headings
Adenocarcinoma; African Americans; Aged; European Continental Ancestry Group; Female; Healthcare Disparities; Humans; Kaplan-Meier Estimate; Male; Medical Oncology; Neoplasm Staging; Pancreatic Neoplasms; Prognosis; Referral and Consultation; Registries; SEER Program; Specialization; Survival Rate; Treatment Outcome; United States
Abstract
BACKGROUND: Blacks have a higher incidence of pancreatic adenocarcinoma and worse outcomes compared to whites. Identifying barriers in pancreatic cancer care may explain survival differences and provide areas for intervention. METHODS: Pancreatic adenocarcinoma patients were identified in the Surveillance, Epidemiology, and End Results Registry (1991-2002). Treatment and outcome data were obtained from the linked Surveillance, Epidemiology, and End Results Registry-Medicare databases. Logistic regression was used to assess race as a predictor of specialist consultation/receipt of therapy. Kaplan-Meier survival curves were compared. Cox proportional hazard analyses were performed to estimate survival after adjustment for patient and treatment characteristics. RESULTS: A total of 13,230 white patients (90%) and 1478 black patients (10%) were identified. Clinical/pathologic factors were compared by race. When we compared whites and blacks by univariate analyses, blacks had lower rates of specialist consultation (P CONCLUSIONS: Racial disparities exist in pancreatic cancer specialist consultation and subsequent therapy use. Because receipt of care is fundamental to reducing outcome discrepancies, these barriers serve as discrete intervention points to ensure all locoregional pancreatic adenocarcinoma patients receive appropriate specialist referral and subsequent therapy.
Rights and Permissions
Citation: Ann Surg Oncol. 2009 Nov;16(11):2968-77. Epub 2009 Aug 11. Link to article on publisher's site
Comments

Jillian Smith participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.

Related Resources
Link to Article in PubMed
PubMed ID
19669839
Citation Information
Melissa M. Murphy, Jessica P. Simons, Sing Chau Ng, Theodore P. McDade, et al.. "Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma" Vol. 16 Iss. 11 (2009) ISSN: 1068-9265 (Linking)
Available at: http://works.bepress.com/jennifer_tseng/24/